Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01080313 · ClinicalTrials.gov registry record
Head and Neck Cancer Registry (LORHAN)
A clinical trial, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- 26,000
- Enrollment target
NCT01080313: Completed study, sponsored by Eli Lilly and Company.
NCT01080313 is a clinical trial that has completed, run by Eli Lilly and Company. The registered enrollment target is 26,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01080313 has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- 26,000 participants
- Enrollment target
Study Summary
The primary objective of this study is to describe, in detail, patterns of care for head and neck carcinoma patient
Interventions
- OTHER Therapy for head and neck cancer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26,000 participants |
| Start Date | 2005-08 |
| Est. Completion | 2011-12 |
What the finished NCT01080313 record still lists
NCT01080313 is an observational study that tracks outcomes without assigning an intervention. Its 26,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Therapy for head and neck cancer is the first listed.
NCT01080313 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01080313 about?
NCT01080313 is a clinical study titled "Head and Neck Cancer Registry (LORHAN)". The primary objective of this study is to describe, in detail, patterns of care for head and neck carcinoma patient
What is the current status of trial NCT01080313?
This trial is currently completed. The enrollment target is 26,000 participants. The study started on 2005-08. Estimated completion is 2011-12.
What interventions are being tested in trial NCT01080313?
The interventions under investigation include: Therapy for head and neck cancer (OTHER).
Who is sponsoring clinical trial NCT01080313?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07300839 · 25,500 participants · Phase 3
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age
- NCT03175302 · 25,240 participants
PREsurgical Cognitive Evaluation Via Digital clockfacEdrawing
- NCT04678193 · 27,000 participants
COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy
- NCT04595201 · 25,000 participants
Clinical Follow-up of Pregnant Subjects Undergoing NIPT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia